Insider Holders & Insider Ownership - Aceragen Inc. (ACGN)

List of insiders holdings for Aceragen Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Pillar Invest Corp
Pillar Pharmaceuticals I LP
Pillar Pharmaceuticals II L.P.
Pillar Pharmaceuticals III L.P.
Pillar Pharmaceuticals IV L.P.
Pillar Pharmaceuticals V LP
Pillar Pharmaceuticals 6 L.P.
Pillar Partners Foundation L.P.
Umari Abude
ZEIN YOUSSEF EL
10% Owner		2020-08-17 16:30:5214,822,075
0		14,822,075Form 13D
OPTIMA LIFE SCIENCE LTD
10% Owner		2003-10-14 10:49:117,150,495
0		7,150,495Form 3
Baker Brothers Life Sciences Capital (GP) LLC
Baker Biotech Capital II (GP) LLC
Baker Biotech Capital II (Z) (GP) LLC
Baker Biotech Capital III (Z) (GP) LLC
BAKER JULIAN
BAKER FELIX
10% Owner		2007-10-31 17:46:113,828,703
0		3,828,703Form 13D
Baker Biotech Capital III (Z) (GP) LLC
BAKER JULIAN
BAKER FELIX
10% Owner		2007-10-31 17:46:113,828,703
0		3,828,703Form 13D
BAKER BROS. ADVISORS LP
14159 L.P.
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director
10% Owner		2021-04-09 17:14:132,088,464
0		2,088,464Form 13G
BAKER BROS. ADVISORS LP
Baker Bros. Advisors (GP) LLC
BAKER FELIX
BAKER JULIAN
10% Owner		2021-04-09 17:14:132,088,464
0		2,088,464Form 13G
Senator Investment Group LP
10% Owner		2013-02-26 15:45:391,370,215
0		1,370,215Form 13G
Chopra Atul
10% Owner		2023-05-18 14:38:040
1,205,158		1,205,158Form 4
NovaQuest Co-Investment Fund XV L.P.
NQ POF V GP Ltd.
See Remarks		2023-01-18 16:54:21909,326
0		909,326Form 13D
WOOTEN RONALD J
Director		2023-01-19 21:47:110
830,294		830,294Form 4
Wolf John Peter III
General Counsel		2014-12-12 20:16:43600,000
0		600,000Form 4
SEILER STEPHEN R
Chief Executive Officer		2003-12-08 12:58:37510,000
100		510,100Form 4
DOUGHERTY MICHAEL R
Director		2023-01-12 20:00:10375,155
0		375,155Form 4
BRENNER LOUIS MD
Chief Medical Officer		2014-12-12 20:14:17350,000
0		350,000Form 4
Baker Biotech Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
10% Owner		2011-09-27 16:51:34288,252
0		288,252Form 13G
Baker Bros. Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
10% Owner		2011-09-27 16:51:34288,252
0		288,252Form 13G
Baker Brothers Life Sciences Capital (GP) LLC
BAKER JULIAN
BAKER FELIX
10% Owner		2011-09-27 16:51:34288,252
0		288,252Form 13G
14159 capital (GP) LLC
BAKER JULIAN
BAKER FELIX
10% Owner		2011-09-27 16:51:34288,252
0		288,252Form 13G
Casey Mark J
Senior VP & General Counsel		2018-01-05 16:19:46270,000
0		270,000Form 4
Arbeit Robert D.
VP Clinical Development		2013-12-12 16:49:21200,000
0		200,000Form 4
Sullivan Timothy M
VP Development Programs		2014-05-29 16:26:18191,565
0		191,565Form 4
AGRAWAL SUDHIR
President of Research		2017-01-06 16:22:46185,000
0		185,000Form 4
MARTIN RUSSELL
Senior VP of Drug Development		2004-04-02 15:21:4498,750
0		98,750Form 4
YINGLING JONATHAN MICHAEL
Chief Scientific Officer		2020-01-14 18:58:4186,358
0		86,358Form 4
Pillar Invest Corp
Pillar Partners Foundation L.P.
Pillar Pharmaceuticals 6 L.P.
Umari Abude
ZEIN YOUSSEF EL
10% Owner		2023-08-03 16:59:5681,187
0		81,187Form 13D
Taylor John Clayton
CHIEF EXECUTIVE OFFICER		2023-02-02 20:06:2574,500
0		74,500Form 4
SOLAND DANIEL B
CHIEF OPERATING OFFICER		2022-07-07 17:30:4866,500
0		66,500Form 4
REARDON WILLIAM S
Director		2018-06-22 16:00:3550,000
0		50,000Form 4
Fletcher Robert C.
Sr. VP, Bus. Dev. & Strategy		2020-07-23 16:35:2650,000
0		50,000Form 4
Horobin Joanna
Chief Medical Officer		2019-07-11 17:18:2845,500
0		45,500Form 4
PIEN HOWARD H
Director		2020-10-05 16:07:4945,457
0		45,457Form 4
HARTLEY C KEITH
Director		2013-08-16 19:55:1140,000
0		40,000Form 4
KARR ROBERT W
Director		2014-06-11 17:56:2235,000
0		35,000Form 4
Slater Eve Elizabeth
Director		2015-06-11 08:10:3635,000
0		35,000Form 4
Arcudi III Louis J
Chief Financial Officer		2018-08-15 16:32:1032,500
0		32,500Form 4
Csimma Cristina
Director		2022-06-27 16:30:2626,000
0		26,000Form 4
GERAGHTY JAMES A
Director		2022-06-27 16:30:3926,000
0		26,000Form 4
SCHAFER CAROL
Director		2022-06-27 16:30:1526,000
0		26,000Form 4
Goldberg Mark Alan
Director		2022-06-27 16:31:1326,000
0		26,000Form 4
Kraus Carl N
CHIEF MEDICAL OFFICER		2023-02-02 20:10:5525,400
0		25,400Form 4
Salain Daniel
CHIEF OPERATING OFFICER		2023-02-02 20:12:4125,400
0		25,400Form 4
JORDAN ANDREW R
CHIEF STRATEGY OFFICER		2023-02-02 20:13:2925,400
0		25,400Form 4
Lim Bryant David
SVP AND GENERAL COUNSEL		2023-02-02 20:08:5725,400
0		25,400Form 4
Kirby John J.
CHIEF FINANCIAL OFFICER		2023-02-02 20:15:0025,400
0		25,400Form 4
Bexon Alice
V.P. Clinical Development		2009-12-24 07:34:5724,000
0		24,000Form 4
MUELLER HANS
Director		2011-06-14 19:09:4720,000
0		20,000Form 4
WYNGAARDEN JAMES B
Director		2011-06-14 19:11:0820,000
0		20,000Form 4
ANDERSEN ROBERT G
CFO & VP Oper. and Planning		2007-05-17 16:01:0015,744
0		15,744Form 4
Tarka Elizabeth Ann
CHIEF MEDICAL OFFICER		2021-03-29 16:14:2913,237
0		13,237Form 4
Alison Taunton-Rigby
Director		2009-06-16 17:39:0410,000
0		10,000Form 4
MILANO VINCENT
Director		2023-08-11 16:30:248,987
0		8,987Form 4
MacCoss Malcolm
Director		2014-07-03 16:25:433,753
0		3,753Form 4
MARCEL GEORGES ANTHONY
Director		2004-01-05 15:24:503,750
0		3,750Form 4
ZAMECNIK PAUL C
Director Emeritus		2008-01-08 16:46:371,250
0		1,250Form 4
Neu Kelvin
Director		2014-03-12 20:23:130
0		0Form 3
GOWEN MAXINE
Director		2023-08-11 16:48:060
0		0Form 4
Abdul-Wahab Umari
Director		2014-05-23 17:21:330
0		0Form 4